Drugsniper, a tool to exploit loss-of-function screens, identifies CREBBP as a predictive biomarker of VOLASERTIB in small cell lung carcinoma (SCLC)

  1. Carazo, F.
  2. Bértolo, C.
  3. Castilla, C.
  4. Cendoya, X.
  5. Campuzano, L.
  6. Serrano, D.
  7. Gimeno, M.
  8. Planes, F.J.
  9. Pio, R.
  10. Montuenga, L.M.
  11. Rubio, A.
Zeitschrift:
Cancers

ISSN: 2072-6694

Datum der Publikation: 2020

Ausgabe: 12

Nummer: 7

Seiten: 1-18

Art: Artikel

DOI: 10.3390/CANCERS12071824 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus